2-37951675-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_144713.5(RMDN2):āc.460T>Cā(p.Phe154Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144713.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RMDN2 | NM_001170791.3 | c.452+21946T>C | intron_variant | ENST00000354545.8 | NP_001164262.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RMDN2 | ENST00000354545.8 | c.452+21946T>C | intron_variant | 1 | NM_001170791.3 | ENSP00000346549.3 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249276Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135120
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461046Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 726822
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.460T>C (p.F154L) alteration is located in exon 2 (coding exon 2) of the RMDN2 gene. This alteration results from a T to C substitution at nucleotide position 460, causing the phenylalanine (F) at amino acid position 154 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at